供应商 · 生产商 · 食品生物技术

TurtleTree

TurtleTree 正以突破性产品 LF+ 开创健康的未来——世界首个以尖端精密发酵技术创造的纯素乳铁蛋白。乳铁蛋白是一种生物活性乳蛋白，可提升广泛食品与健康产品的营养谱：从植物基替代品和传统食品到护肤与化妆品，LF+ 都能提供卓越的健康益处；我们的创新工艺不仅造福人类健康，也确保动物过上无忧、更快乐的生活。在持续拓展食品科学边界的同时，我们正寻找伙伴和投资者，共创健康、可持续的未来——加入健康革命：营养，遇见人性。

运营中新加坡亚洲成立 2019 核实于 2026-10-05

简介

TurtleTree is a private biotechnology company that uses precision fermentation to produce sustainable, animal-free lactoferrin (its LF+ / “Pink Gold™” ingredient) for food, beverages, early-life nutrition, and supplements; LF+ is FDA GRAS “No Questions/No Objection Letter”. It was founded in 2019 and is based in Singapore (HQ listed as 79 Ayer Rajah Crescent #05-03, Block 79, Singapore 139955). In July 2026, it signed an agreement with Novonesis for exclusive scaling/manufacturing/commercialization for early-life nutrition and received a minority investment from Novonesis plus 321Catalyst Ventures. TurtleTree is incorporated as TURTLETREE LABS PTE. LTD. and is Active. Reported employees: 18. Investors/funding disclosed: raised ~$39.4M total and has Series A; investors include VERSO Capital, KBW Ventures, Green Monday, Eat & Beyond Global, and others. Latest 2025–2026 developments: FDA “No Questions” GRAS letter in May 2025 and the Novonesis scaling/commercialization deal in July 2026; the company remains active.

Sources#

行业: 替代蛋白, 化妆品, 生物工艺设备, 食品配料
主题: 精密发酵（蛋白质、乳制品、蛋类）, 植物基肉、乳、蛋, 透明质酸、胶原蛋白与化妆品生物活性成分
角色: 生产商 — “…nesis for exclusive scaling/manufacturing/commercialization for early-life nutrition and received a minority i…”

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

该公司未公开其产品或服务——我们可通过引荐了解。

新闻与状态 6

2026-07 最新状态: TurtleTree 与诺和新元（Novonesis）建立独家伙伴关系并获其少数股权投资，以规模化、制造和商业化其精密发酵乳铁蛋白（LF+）。 ↗ ↗ ↗
2026-07-16 Novonesis and TurtleTree enter partnership to support commercialization of lactoferrin
TurtleTree is a precision fermentation company that has developed LF+®, a lactoferrin product for early life nutrition and dietary supplements, and is the first to receive US FDA GRAS status for precision-fermented lactoferrin. The company partnered with …
2026-07-08 TurtleTree, Novonesis partner on precision-fermented lactoferrin
TurtleTree, shifting from cell-cultured milk to a precision fermentation platform, is partnering with Novonesis (with participation from Mitsui’s 321Catalyst) to scale lactoferrin production and move toward food-scale manufacturing, supported by a minority …
2026-09-07 TurtleTree turns FDA-Cleared Lactoferrin into a scale-up bet with Novonesis
TurtleTree has achieved a major milestone by securing FDA GRAS clearance for precision-fermented lactoferrin (LF+) and partnering with Novonesis to scale, manufacture, and commercialize LF+ for early life nutrition. The deal positions TurtleTree to move from …
2026-07-08 TurtleTree bags new capital to scale lactoferrin output
TurtleTree has raised new funding from Novonesis and Mitsui Chemicals to accelerate commercialization, manufacturing efficiency, and global expansion of its animal-free lactoferrin products, including its IronKind brand, with plans to enter dietary supplements …
2026-07-07 TurtleTree Labs Pte. Ltd. announced that it has received funding from 321Catalyst Ventures, Inc., Novozymes A/S | MarketScreener
TurtleTree Labs Pte. Ltd. announced that it has received funding from 321Catalyst Ventures, Inc. and Novozymes A/S. The investment involves convertible preferred shares as part of a funding round.
2026-09-29 Turtle Tree labs a biotech firm develops milk without cows using cells based technology - Dairy News 7x7
TurtleTree Labs is a Singapore-based biotech startup developing milk made from mammalian cells instead of cows, aiming to replicate regular milk’s composition and taste while addressing sustainability concerns. The company has attracted significant funding and …

关系网络：股东、合作伙伴、同类

股权与投资方 1

投资方

Novonesis

合作与交易 1

交易对手	Novonesis …TurtleTree entered into an exclusive partnership and received a minority investment from Novonesis to scale, manufacture, and commercialize its precision-fermented lactoferrin (LF+).…

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录